These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 17009941)

  • 41. European surveillance of antimicrobial resistance in Neisseria gonorrhoeae.
    Cole MJ; Chisholm SA; Hoffmann S; Stary A; Lowndes CM; Ison CA;
    Sex Transm Infect; 2010 Nov; 86(6):427-32. PubMed ID: 20940154
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cephalosporin-resistant gonorrhea: it's just a matter of time.
    Deresinski S
    AIDS Alert; 2011 Oct; 26(10):115-6. PubMed ID: 22096785
    [No Abstract]   [Full Text] [Related]  

  • 43. The outcome of oropharyngeal gonorrhoea treatment with different regimens.
    Harry TC
    Int J STD AIDS; 2005 Jul; 16(7):520. PubMed ID: 16004640
    [No Abstract]   [Full Text] [Related]  

  • 44. Prevalence of and associated risk factors for fluoroquinolone-resistant Neisseria gonorrhoeae in California, 2000-2003.
    Bauer HM; Mark KE; Samuel M; Wang SA; Weismuller P; Moore D; Gunn RA; Peter C; Vannier A; DeAugustine N; Klausner JD; Knapp JS; Bolan G
    Clin Infect Dis; 2005 Sep; 41(6):795-803. PubMed ID: 16107976
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Core groups, antimicrobial resistance and rebound in gonorrhoea in North America.
    Chan CH; McCabe CJ; Fisman DN
    Sex Transm Infect; 2012 Apr; 88(3):200-4. PubMed ID: 22169277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antimicrobial sensitivity of Neisseria gonorrhoeae: a hospital-based study from Kuwait.
    Sharma AK; Al-Mutairi N; Zaki A; Nour-Eldin O; Joshi A; Rijhwani M; Al-Tayeh MY; Sultan AM
    J Chemother; 2005 Feb; 17(1):117-8. PubMed ID: 15828455
    [No Abstract]   [Full Text] [Related]  

  • 47. Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains.
    Jones RN; Biedenbach DJ; Ambrose PG; Wikler MA
    Diagn Microbiol Infect Dis; 2008 Sep; 62(1):110-2. PubMed ID: 18620833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of quinolone-resistant Neisseria gonorrhoeae in urogenital specimens with the use of real-time polymerase chain reaction.
    Siedner MJ; Pandori M; Leon SR; Barry PM; Espinosa BJ; Hall ER; Coates TJ; Klausner JD;
    Int J STD AIDS; 2008 Jan; 19(1):69-71. PubMed ID: 18275657
    [No Abstract]   [Full Text] [Related]  

  • 49. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006.
    Su X; Jiang F; Qimuge ; Dai X; Sun H; Ye S
    Sex Transm Dis; 2007 Dec; 34(12):995-9. PubMed ID: 17595594
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Clinical bacterial study of drug resistance of gonococci. Preliminary note].
    Fazio M; Gentili G
    G Ital Dermatol Minerva Dermatol; 1970 Mar; 45(3):163-4. PubMed ID: 4986456
    [No Abstract]   [Full Text] [Related]  

  • 51. Gonococcal infections: new methods of treatment.
    Lutz B
    Compr Ther; 1982 Jun; 8(6):47-52. PubMed ID: 6213356
    [No Abstract]   [Full Text] [Related]  

  • 52. Antibiotic sensitivity of Neisseria gonorrhoeae recorded in a Bombay hospital in 1979-80.
    Gohil AH; Kelkar SS
    Indian J Med Res; 1985 Oct; 82():304-10. PubMed ID: 3935579
    [No Abstract]   [Full Text] [Related]  

  • 53. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Apr; 56(14):332-6. PubMed ID: 17431378
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emergence and spread of azithromycin-resistant Neisseria gonorrhoeae in Scotland.
    Palmer HM; Young H; Winter A; Dave J
    J Antimicrob Chemother; 2008 Sep; 62(3):490-4. PubMed ID: 18552343
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2000.
    Commun Dis Intell Q Rep; 2001 Nov; 25(4):274-6. PubMed ID: 11806663
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibiotic-resistant gonococci - past, present and future.
    Lewis DA
    S Afr Med J; 2007 Nov; 97(11 Pt 3):1146-50. PubMed ID: 18250926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Future treatment of gonorrhea--novel emerging drugs are essential and in progress?
    Unemo M; Shafer WM
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):357-60. PubMed ID: 25907334
    [No Abstract]   [Full Text] [Related]  

  • 58. High prevalence of quinolone resistance in Neisseria gonorrhoeae in coastal Kenya.
    Duncan S; Thiong'o AN; Macharia M; Wamuyu L; Mwarumba S; Mvera B; Smith AD; Morpeth S; Graham SM; Sanders EJ
    Sex Transm Infect; 2011 Apr; 87(3):231. PubMed ID: 21307154
    [No Abstract]   [Full Text] [Related]  

  • 59. Antimicrobial susceptibility profile of resistance phenotypes of Neisseria gonorrheae in India.
    Bala M; Jain RK; Ray K
    Sex Transm Dis; 2008 Jun; 35(6):588-91. PubMed ID: 18418302
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Control of Neisseria gonorrhoeae in the era of evolving antimicrobial resistance.
    Barbee LA; Dombrowski JC
    Infect Dis Clin North Am; 2013 Dec; 27(4):723-37. PubMed ID: 24275266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.